Sanara MedTech CEO Yon Seth D forfeited 3,661 shares at $35.11 per share, leaving him with 105,885 shares. The transaction represented about 3.3% of his prior share holding and was classified under code F, which denotes tax-related Withholding in SEC transaction coding.
Key Highlights
- The transaction represented about 3.3% of Yon Seth D’s prior share holding.
- SEC transaction code F identifies the forfeiture as tax-related withholding.
- Yon Seth D was identified as Sanara MedTech Inc.’s Chief Executive Officer.
Sanara MedTech Inc. (NASDAQ: SMTI) said Chief Executive Officer Yon Seth D forfeited 3,661 shares. The affected security was Sanara MedTech Inc. stock, and the reported price was $35.11 per share. Yon Seth D’s stated ownership after the transaction was 105,885 shares. Yon Seth D was identified as Sanara MedTech Inc.’s Chief Executive Officer in the transaction details. The affected security was Sanara MedTech Inc. shares.
3.3% of Prior Share Holding
The forfeiture represented about 3.3% of his prior share holding. That percentage is measured against the shares held before the transaction, while the 105,885 figure describes the position afterward. The two figures therefore refer to different points in the ownership sequence, with the percentage tied to the earlier holding and the share count tied to the later one.
FAQs
Q: How many Sanara MedTech shares did Yon Seth D forfeit?
A: Yon Seth D forfeited 3,661 Sanara MedTech shares at $35.11 per share. The transaction occurred on Sep 15, 2026, and used SEC transaction code F.
Q: How many SMTI shares did Yon Seth D own after the transaction?
A: Yon Seth D owned 105,885 Sanara MedTech shares after the transaction. The reported forfeiture represented about 3.3% of his prior share holding.
Q: What does code F mean in Yon Seth D’s SMTI transaction?
A: The classification applied to Yon Seth D’s forfeiture of Sanara MedTech shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.